If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site

WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

Periocular Hygenix (POHx™ )

What is it?

A group of non-surgical clinical treatments that targets the eyelid surface and internal oil glands (meibomian glands) to clinically remove or ‘scale’ keratinized tissue (dead skin) , as well as clearing gland obstructions of the upper and lower eyelids.

Line of Treatments

  • Comprehensive Periocular Cleaning—This procedure includes a scaling of excess tissue at the lid margin and inner eyelid as well as clearing of biological debris at the eyelash root and follicle using non-surgical instruments
  • Periocular Scaling/Gland Expression—This procedure includes careful scaling of the upper and lower eyelid’s inner and outer surface using specialized dyes and non-surgical instruments. Included is a superficial clearing of the meibomian glands
  • BlephEx™—This procedure includes clinical grade cleaning of biological debris and mites from the eyelash root and follicle
  • Thermal Periocular Cleaning—External thermal application combined with periocular cleaning and gland expression

Is it safe?
Yes, all treatments are non-surgical and require only topical anesthesia. Most patients experience mild soreness and irritation lasting up to an hour after treatment. No serious adverse reactions have ever been reported at eyeLABS.
Why hasn’t my doctor told me about this before?
Dr. Maharaj is a respected expert in the field of ocular surface disease and lectures across North America on the subject. Many of our treatments have been researched and developed through his work at eyeLABS. Because Periocular Hygenix is new to the eye care industry, many doctors haven’t had the clinical experience or training required to perform such techniques. 
What results can I expect?
The Maharaj Triad technique, a key element of POHx™ patients. On average, patients had 62% improved validated symptoms and a 33% increase in gland functioning by expression. LipiFlow Thermal Pulsation in eyeLABS clinical testing showed significant improvement in 90% of patients, mild-moderate improvement in 7%, and little to no effect in 3%. LipiFlow is FDA approved for the treatment of evaporative dry eye disease and meibomian gland dysfunction.